In the following video, Max Malcaluso interviews Fool banking analyst David Hanson regarding the "London Whale" incident at JPMorgan Chase (NYSE: JPM ) .
David explains that the job of the London Whale, a former JPMorgan trader based in (NYSE: JPM ) London,� was to safely invest excess capital and mitigate risk using strategies including asset hedging, if appropriate. He placed directional bets made to appear similar to a hedge, and the market started to move against him.
David discusses how senior management handled the situation when they were alerted to the magnitude of the trading loss, and he shares his view about the size of the trading loss as it relates to both JPMorgan's overall financial performance, and for investor confidence moving forward.
With big finance firms still trading at deep discounts to their historic norms, investors everywhere are wondering if this is the new normal, or if finance stocks are a screaming buy today. The answer depends on the company, so to help figure out whether JPMorgan is a buy today, check out The Motley Fool's premium research report on the company. Click here now for instant access!
Top 10 Clean Energy Stocks To Invest In Right Now: Shenandoah Telecommunications Co(SHEN)
Shenandoah Telecommunications Company, a diversified telecommunications company, provides regulated and unregulated telecommunications services to end-user customers and other communications providers in the southeastern United States. It offers a suite of voice, video, and data communications services; and sells telecommunications equipment. The company?s Wireless segment provides digital wireless service to a portion of a four-state area covering the region from Harrisburg, York, and Altoona, Pennsylvania to Harrisonburg, Virginia. It owns 149 towers and leases tower space to other wireless communications providers in Virginia, West Virginia, Maryland, and Pennsylvania. This segment also offers personal communications services through a digital wireless telephone and data network. Its Wireline segment provides regulated and unregulated telephone services and leases fiber optic facilities primarily in the northern Shenandoah Valley. This segment also offers information s ervices and Internet access to customers in the northern Shenandoah Valley and surrounding areas. In addition, it is involved in the resale of long distance service for calls placed to locations outside the regulated telephone service area by telephone customers. As of December 31, 2011, this segment had approximately 1,410 dial-up customers and 12,351 digital subscriber line customers, as well as served approximately 10,483 long distance customers. The company?s Cable Television segment provides coaxial cable-based television service in the portions of Shenandoah County, Virginia, as well as in communities in West Virginia, southern and southwestern Virginia, and western Maryland. It had approximately 137,238 cable revenue generating units. The company was founded in 1902 and is headquartered in Edinburg, Virginia.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Wednesday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Horizon Pharma (NASDAQ: HZNP) and Pernix Therapeutics Holdings (NASDAQ: PTX). In trading on Wednesday, telecommunications services shares were relative laggards, down on the day by about 0.39 percent. Top decliners in the sector included Shenandoah Telecommunications Co (NASDAQ: SHEN), off 3.3 percent, and CalAmp (NASDAQ: CAMP), down around 2.4 percent.
Top 5 Heal Care Stocks To Watch Right Now: Continental AG (CON)
Continental AG is a Germany-based holding company and automotive industry supplier. It operates two business groups: Automotive Group and Rubber Group. The Automotive Group is divided into Chassis & Safety division, Powertrain division and Interior division. The Chassis & Safety division focuses on the areas of networked driving safety, brakes, driver assistance, chassis, active and passive safety and sensor technology for the avoidance of accidents and injury. The Powertrain division specializes in the powertrain solutions. The Interior division focuses on information, communication and networking solutions. The Rubber Group is divided into Tire division and ContiTech divisions. The Tire division comprises Passenger and Light Truck Tires, including tires for motorcycles. The ContiTech division develops and manufactures functional parts, components and systems for the automotive industry. In February 2014, it acquired Veyance Technologies Inc. Advisors' Opinion:- [By Ruth David]
Schaeffler AG, the largest investor in Hanover, Germany-based Continental AG (CON), raised 950 million euros on Sept. 17 by selling a 4 percent stake in Europe�� second-largest car-parts maker to reduce debt. Telegraaf Media Groep NV, the publisher of the largest Dutch newspaper, exited its holding in German broadcaster ProSiebenSat.1 Media AG on Sept. 6, making proceeds of about 391 million euros.
- [By Jonathan Morgan]
Volkswagen, Europe�� biggest automaker, gained 3.7 percent to 168.40 euros. Daimler AG, the third-biggest luxury-vehicle maker, rose 3.9 percent to 49 euros, its highest price since August 2011. Continental AG (CON), Europe�� second-largest auto-parts maker, added 3 percent to 100.30 euros. A measure of carmakers posted the best performance of the 19 industry groups on the Stoxx Europe 600 Index.
Top 5 Heal Care Stocks To Watch Right Now: Spectrum Rare Earths Ltd (SPX)
Spectrum Rare Earths Limited, formerly TUC Resources Ltd, is engaged in the exploration and evaluation of rare earths, uranium, base metals and gold mineral interests. On October 2, 2012, holds approximately 18,000 square kilometer of prospective land package across 44 tenements. During the fiscal year ended June 30, 2011, the Company is focuses on its Stromberg Heavy Rare Earth Project. The Company has 50, 100% owned tenements in the Northern Territory. Tenements within the Pine Creek Project consist of EL's 24884, 25224, 25228 and uranium rights on EL24906. Parts of EL24906 and EL24884 are located within the Rum Jungle Mineral Field. The Arnhem Project encompasses all the Company�� tenement holdings in the East Alligator River region within 150 kilometer of the high grade Narbalek uranium mine. The Litchfield Uranium Project consists of granted licenses EL25195 and EL25176 and license applications 25472, 25473 and 25221. Advisors' Opinion:- [By Adam Haigh]
Futures on the Standard & Poor�� 500 Index (SPX) rose 0.4 percent. Financial and energy shares tumbled yesterday, leading the S&P 500 to its largest drop in five weeks, as ADP Research Institute data showed U.S. companies boosted employment by 158,000 workers in March, less than the median forecast of 39 economists surveyed by Bloomberg who called for a 200,000 gain.
Top 5 Heal Care Stocks To Watch Right Now: Evoke Pharma Inc (EVOK)
Evoke Pharma, Inc., incorporated on January 29, 2007, is a specialty pharmaceutical company. The Company is focused primarily on the development of drugs to treat gastrointestinal (GI), disorders and diseases. The Company is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The Company�� lead product candidate, EVK-001, is in late stage clinical testing. EVK-001 is a formulation of this drug, designed to provide systemic delivery of metoclopramide through intranasal administration.
Gastroparesis is a condition of delayed gastric emptying in the absence of mechanical obstruction. Gastroparesis results in food remaining in the stomach for a longer time than normal, yielding a variety of symptoms. Gastroparesis is a common problem in individuals with diabetes, but also is observed in patients with prior gastric surgery, a preceding infectious illness, pseudo-obstruction, collagen vascular disorders and anorexia nervosa. EVK-001 is designed to effectively bypass the digestive system and allow for more predictable drug administration of its nasal spray formulation across the thin mucosa in the nasal cavity.
Advisors' Opinion:- [By MONEYMORNING.COM]
The first, Evoke Pharma Inc. (Nasdaq: EVOK), will release data from a phase 3 trial of its experimental drug EVK-001, a potential treatment for women with recurrent diabetic gastroparesis. The data follows successful results from a previous phase 2 study of the drug.
No comments:
Post a Comment